Reaction

Reversible Cerebral Vasoconstriction Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,937 reports · 61 co-occurring drugs

As of the last recalculation, Reversible Cerebral Vasoconstriction Syndrome appears in 1,937 FAERS reports alongside 61 co-occurring drug terms. The strongest observed disproportionality signal is SUMATRIPTAN SUCCINATE (PRR 51.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Sumatriptan Succinate	115	51.9	52.1
Norepinephrine	31	31.7	31.7
Sumatriptan	103	30.6	30.7
Escitslopram	149	29.7	29.8
Norepinephrine Bitartrate	39	29.7	29.8
Escitalopram Oxalate	165	26.5	26.5
Basiliximab	28	25.9	26.0
Fluoxetine	134	23.1	23.2
Paroxetine Hydrochloride Hemihydrate	57	18.9	18.9
Nicotine Polacrilex Mini	26	18.9	18.9
Nicotine Polarilex	26	18.9	18.9
Paroxetine	57	18.5	18.6
Venlafaxine	112	17.8	17.8
Duloxetine	102	16.5	16.6
Ketoprofen	18	14.9	14.9
Fluoxetine Hydrochloride	162	14.8	14.8
Escitalopram	168	14.0	14.0
Rizatriptan Benzoate	13	13.8	13.8
Methylprednisolone	161	13.6	13.6
Human Immunoglobulin G	25	13.2	13.2
Aripiprazole Oral	49	13.0	13.1
Aripiprazole Orally Disintegrating	49	13.0	13.1
Acetaminophen, Aspirin (Nsaid) And Caffeine	18	11.5	11.5
Mycophenolate Mofetil	134	11.3	11.3
Mycophenolate Mofetil Hydrochloride	134	11.3	11.3
Dorzolamide Hydrochloride And Timolol Maleate	8	10.9	10.9
Tacrolimus Ointment 0.1%	119	10.9	10.9
Tacrolimus Extended-Release Capsules	119	10.8	10.9
Bupropion	43	10.6	10.6
Tacrolimus	140	10.3	10.3
Zonisamide	14	10.2	10.2
Venlafaxine Hydrochloride	118	10.1	10.1
Alpelisib	8	9.9	9.9
Methylphenidate Hydrochloride	53	9.9	9.9
Rasagiline Mesylate	10	9.7	9.7
Mycophenilic Acid	18	9.4	9.4
Anti-Thymocyte Globulin (Rabbit)	7	9.4	9.4
Sertraline	97	9.3	9.3
Acetaminophen, Aspirin, And Caffeine	18	9.3	9.3
Atropine	7	9.1	9.1
Methylphenidate	24	9.0	9.0
Atropine Sulfate	9	9.0	9.0
Nicotine Polacrilex	31	8.8	8.8
Citalopram Hydrobromide	83	8.6	8.7
Pseudoephedrine Hydrochloride	8	8.4	8.4
Oxcarbazepine	25	8.4	8.4
Paroxetine Hydrochloride	66	8.0	8.0
Pseudoephedrine Hcl	8	7.8	7.8
Nicotine	29	7.8	7.8
Dextrose	9	7.4	7.4
Dextrose Monohydrate	9	7.3	7.3
Adrenalinum	27	7.1	7.1
Everolimus Tablets	10	6.4	6.4
Aripiprazole	61	5.5	5.5
Panitumumab	7	4.8	4.8
Liraglutide	19	4.2	4.2
Fremanezumab-Vfrm	4	3.7	3.8
Ranibizumab	8	3.2	3.2
Abemaciclib	6	3.2	3.2
Relugolix	7	3.2	3.2
Copper	6	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.